Abstract
In the 14 years since this quote, the empirical study of merger remedies has seen little advancement despite frequent use of remedies in practice, significant policy interest, and a treasure trove of potential research topics. This article first describes the use of remedies in U.S. merger policy, including a summary of the FTC’s recent remedy study. It then provides a review of empirical literature addressing remedy effectiveness, with only two modern retrospectives of domestic merger remedies. The article concludes by highlighting areas where economic research could further advance the study of merger remedies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
